Related Experiment Video
Updated: Jun 8, 2025

Detection and Quantification of Calcitonin Gene-Related Peptide CGRP in Human Plasma Using a Modified Enzyme-Linked Immunosorbent Assay
Published on: June 16, 2023
A Case of Abnormal Elevation of Serum CA 72-4 Caused by Colchicine
Background:
CA 72-4 is a tumor associated antigen which shows significantly increased serum levels in gastric cancer. It is the most commonly used serum tumor marker for diagnosing symptomatic gastric cancer and monitoring gastric cancer treatment.
Methods:
We report the case of a gout patient with abnormal elevation of serum CA 72-4 caused by taking colchicine.
Results:
The patient's painless gastroscopy and other examinations showed no obvious abnormalities, and no detection interference was detected. After discontinuing treatment with colchicine, CA 72-4 level of the patient returned to normal. Therefore, the abnormal increase of CA 72-4 is believed to be caused by colchicine.
Conclusions:
When gout patients receive colchicine treatment, it may lead to an abnormal increase in CA 72-4 results. Laboratory staff should consider the existence of such interference and promptly remind clinical doctors to avoid unnecessary examination and treatment of patients.
More Related Videos
Related Concept Videos
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Drugs for Treatment of Ulcerative Colitis in IBD
Chronic Pancreatitis II: Collaborative Care
Assessment:
Pericarditis II: Clinical features and Diagnostic Tests

